Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine and Escitalopram in Elderly Depressed Patients with Cognitive Impairment
NCT01876823Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Apr 2006
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in Mild Cognitive Impairment (MCI), sponsored by New York State Psychiatric Institute. Started Apr 2006; status: completed.
02
Drugs
memantine
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01876823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01876823.